Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer’s Disease
Author:
Affiliation:
1. Virginia Commonwealth University Parkinson’s Center, Richmond, VA, USA
2. Neurodegeneration Therapeutics, Inc., Charlottesville, VA, USA
3. University of Kansas School of Medicine Alzheimer’s Disease Center, Kansas City, KS, USA
Publisher
IOS Press
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Reference17 articles.
1. Dementia: A global health priority - highlights from an ADI and World Health Organization report;Wortmann;Alzheimers Res Ther,2012
2. Monetary costs of dementia in the United States;Hurd;N Engl J Med,2013
3. Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain;Thal;Exp Gerontol,2012
4. The pathogenesis of Alzheimer’sdisease: A reevaluation of the “amyloid cascade hypothesis”;Armstrong;Int J Alzheimers Dis,2011
5. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers;Shaffer;Radiology,2013
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance;Process Biochemistry;2023-09
2. Similarity measures-based graph co-contrastive learning for drug–disease association prediction;Bioinformatics;2023-06-01
3. Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s disease;Inflammopharmacology;2023-03-18
4. Dexpramipexole ameliorates cognitive deficits in sepsis-associated encephalopathy through suppressing mitochondria-mediated pyroptosis and apoptosis;NeuroReport;2023-01-20
5. Multi-layer guilt-by-association-based drug repurposing by integrating clinical knowledge on biological heterogeneous networks;2022-11-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3